FDA revising promotion guidances, says Abrams

Share this article:
Tom Abrams
Tom Abrams

The FDA is revising two drug-promotion guidances, CDER Office of Drug Product Promotion director Tom Abrams told a Drug Information Association annual meeting session in June.

FDA's Brief Summary guidance is being re-worked, he said, “based on data analyses of three OPDP social science communication research studies.” Public docket comments were also considered. The other guidance being revised is the Presentation of Risk Information in Promotional Materials guidance. This revision is also based on public comments, Abrams told DIA.

Abrams said he has seen an improvement in voluntary compliance and the quality of healthcare promotions. But “while there has been progress,” he says, “we still have a ways to go.”

Abrams said there has been a lot of interest in how advertising and promotion enforcement will be affected by the Caronia decision, in which the US Court of Appeals for the Second Circuit vacated a criminal conviction of Alfred Caronia, a former Orphan Medical sales rep accused of promoting Xyrem to a doctor for off-label uses.

Abrams said FDA has no plans to change its advertising and promotion enforcement approach in the wake of Caronia.

More generally, he said the decision “does not strike down any of the provisions of the Food, Drug and Cosmetic Act or its implementing regulations.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.